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Abstract
In mice, Quaking (Qk) is required for myelin formation; in humans, it has been associated with psychiatric disease. QK
regulates the stability, subcellular localization, and alternative splicing of several myelin-related transcripts, yet little is
known about how QK governs these activities. Here, we show that QK enhances Hnrnpa1 mRNA stability by binding a
conserved 39 UTR sequence with high affinity and specificity. A single nucleotide mutation in the binding site eliminates QK-
dependent regulation, as does reduction of QK by RNAi. Analysis of exon expression across the transcriptome reveals that
QK and hnRNP A1 regulate an overlapping subset of transcripts. Thus, a simple interpretation is that QK regulates a large set
of oligodendrocyte precursor genes indirectly by increasing the intracellular concentration of hnRNP A1. Together, the data
show that hnRNP A1 is an important QK target that contributes to its control of myelin gene expression.
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Myelin is a lipid-rich structure that facilitates the propagation of
electrical impulses along neuronal axons and protects them from
degeneration [1–3]. In the central nervous system (CNS), myelin is
produced by oligodendrocytes, glial cells that ensheathe nearby
axons with specialized cytoplasmic processes. Defects in the
formation and maintenance of myelin cause several devastating
diseases in humans, including multiple sclerosis, leukodystrophy,
and Pelizaeus-Merzbacher disease.
In the mouse, myelin formation requires QK, a STAR domain
RNA-binding protein that regulates gene expression after
transcription [4]. The quaking viable (Qk
qk) mutation, which causes
a pronounced tremor, was discovered over forty years ago [5]. The
phenotype is caused by the failure to form compact myelin in the
CNS and derives from a large deletion lying upstream of the
Quaking (Qk) locus [6]. The Qk
qk mutation eliminates oligoden-
drocyte expression of two cytoplasmic QK splice isoforms, QK-6
and QK-7, and reduces expression of a third nuclear isoform, QK-
5, primarily in the more severely affected rostral areas [7]. In Qk
qk
mice, expression of QK-6 under the control of the oligodendro-
cyte-specific proteolipid protein gene (Plp1) promoter rescues the
myelin defect, demonstrating that QK-6 alone suffices to restore
QK function [8]. Other alleles of Qk are embryonic lethal, except
for the Qk
e5 allele identified by Justice and coworkers that also
causes severe demyelination [9].
QK is a multifunctional protein proposed to control myelin
formation through three different mechanisms. First, QK stabilizes
the myelin basic protein (Mbp), microtubule associated protein 1B
(Map1b), and p27
Kip1 mRNAs in the brain or in cultured
oligodendrocytes [10–12]. Second, QK controls the subcellular
distribution of Mbp mRNA, such that an increase in the ratio of
nuclear to cytoplasmic QK isoforms drives nuclear retention of
Mbp mRNA and reduces Mbp translation [13]. Finally, QK
regulates alternative splicing of Mbp, Plp1, and myelin associated
glycoprotein (Mag) mRNAs [14]. Qk
qk mutant brains display
altered isoform ratios of Mbp, Plp1, and Mag transcripts, and
splicing of a Mag mini-gene is altered in the presence of exogenous
QK-5 in cultured COS-7 cells [14]. How QK controls such
diverse processes is unclear.
Quaking has recently been implicated in several human
psychiatric diseases. Human Quaking (QKI) has been proposed
to be a candidate gene for schizophrenia (SCZ). Genetic linkage
analysis has identified a 0.5 Mb haplotype in the region of QKI
that segregates with SCZ in a large Swedish pedigree [15].
Moreover, SCZ brains have a number of similarities with the
brains of Qk
qk mice, including downregulation of QKI and a
number of other myelin-related genes, including MBP, MAG, and
PLP11 [16–18]. Additionally, like Qk
qk brains, SCZ brains contain
a number of mRNAs that are present at abnormal splice isoform
ratios [19–22]. Some of these, including Mag, are also mis-spliced
in the Qk
qk mouse, suggesting that splicing alterations in the Qk
qk
mouse and in SCZ brains could share a common mechanism [16].
Other clinical phenotypes in which disruptions in QK function are
thought to contribute to disease include major depressive disorder
and 6q terminal deletion syndrome [23,24].
Despite the importance of QK for myelination and its
implications for human health, relatively few direct targets have
been identified. Thermodynamic binding analysis and SELEX
have shown that the sequence element ACUAAY, alternatively
termed the Quaking Star Binding Element (QSBE) or Quaking
Response Element (QRE), is required for a high affinity
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[25,26]. Additionally, a recent cross-link immunoprecipitation
study using chemically modified nucleotides detected binding to
the sequence ACUAAY and an additional sequence variant
AUUAAY [27]. It remains unclear how binding affinity in vitro
correlates to binding site occupancy and regulation in vivo. The
relative simplicity of the binding determinant, which is predicted
to occur approximately once per kb of random RNA sequence,
suggests that the binding element may not be sufficient to specify
mRNA targets [28]. A single QSBE is present within the 39UTR
of Mbp mRNA in a region required for post-transcriptional
regulation of Mbp expression [25,26]. However, a region of Mag
pre-mRNA that has been shown experimentally to drive QK-
dependent splicing events does not contain a QSBE or the variant
AUUAAY [14]. Here, we set out to determine whether the QK
binding element mediates QK-dependent regulation in Mbp and
other regulatory targets. We show that QK regulation of Mbp
expression requires the QSBE. Additionally, we identify a novel
target, Hnrnpa1 mRNA, and show that QK regulates Hnrnpa1
expression in a similar fashion to Mbp. Finally, we show that
hnRNP A1 contributes to QK control of myelin gene expression in
genome wide analyses.
Results
The QSBE is a functional regulatory element within the
Mbp 39 UTR
It has previously been shown that QK interacts with a region of
the Mbp 39 UTR and that the core element required for the
interaction is the sequence ACUAAY [25,26]. SELEX experi-
ments suggest that a nearby YAAY may also contribute to target
selection [26]. We asked whether the QSBE is required for post-
transcriptional regulation of mRNA by QK.
To test whether the QSBE is a required element within the Mbp
39 UTR, we established a quantitative two-color fluorescence
reporter assay in CG-4 oligodendrocyte precursor cells, an
immortalized cell line (Figure 1A, Figure S1A, S1B, S1C) [29].
CG-4 cells can be maintained in culture as progenitors or induced
to differentiate into mature oligodendrocytes, can be transfected,
and express QK and a relevant QK target population.
Additionally, their use avoids the potential complications of the
Qk
qk mouse, in which the genetic lesion lies upstream of the Qk
locus and deletes parts of two additional genes [6,30]. A complete
Qk knockout is embryonic lethal [31].
We compared expression of a GFP reporter bearing the Mbp 39
UTR to a reporter bearing a mutant Mbp 39 UTR harboring a U
to G point mutation that blocks binding of QK to the RNA
(Figure 1B) [25]. All other aspects of the constructs were identical.
We observed three-fold less reporter mRNA in cells transfected
with the mutant construct compared to the wild type (relative
expression 0.3660.07, p=0.02) (Figure 1C). In contrast, GFP
reporter fluorescence increased by a small amount as a result of
the mutation (relative expression 1.3860.20, p=0.04) (Figure 1C).
Dividing the protein expression by the mRNA expression gives a
representation of the efficiency of mRNA translation [32]. The
QSBE mutant yields four-fold more reporter protein per unit
RNA compared to the wild-type reporter (relative value
3.8360.93, p=0.03) (Figure 1C). In total, we observed two
opposing effects of the QSBE in the Mbp 39 UTR: a positive effect
on mRNA level and a negative effect on the efficiency of
translation. These results demonstrate that the QSBE is a
functional cis-regulatory element within the Mbp 39 UTR and
are consistent with published findings that QK positively controls
Mbp mRNA stability and negatively controls its translation
through nuclear retention of its mRNA [10,13].
QK interacts with a QSBE within the 39 UTR of the
Hnrnpa1 mRNA
In addition to promoting mRNA stability, QK regulates
alternative splicing. However, the sequence that has been
experimentally shown to drive QK dependent splicing, the Mag
splicing control element, does not contain the QSBE sequence or
the variant AUUAAY [14]. Moreover, recombinant QK does not
interact with the Mag splicing control sequence or the splicing
control sequence of another QK target, Plp1, by electromobility
shift assays [33,34] (Figure S2). The site of QK binding could lie
distal to the minimal QK-responsive splicing elements that have
been described. Alternatively, accessory proteins found in the
nucleus might modify QK binding specificity, bringing it to other
targets. A third and simpler possibility is that the effect of QK on
alternative splicing could be a secondary consequence of
deregulation of another factor.
To test the final hypothesis, we first determined the ability of
QK to associate with five splicing factor mRNAs (Hnrnpa1, Tra2b,
Sfrs5, Prpf4b, and Slu7) that contain a QSBE in their 39 UTRs by
RNA-immunoprecipitation from mouse brain lysate. We were
unable to detect an interaction between QK and Sfrs5, Tra2b,
Prpf4b, and Slu7 mRNAs using an anti-QK antibody that
recognizes all three QK isoforms (Figure S3). In contrast, we
observe association of QK with Hnrnpa1 mRNA, which contains a
single QSBE sequence within a conserved region of its 39 UTR
(Figure 2A), in both uncrosslinked and formaldehyde crosslinked
brain lysates (Figure 2B, 2C). In uncrosslinked brain lysates, QK
antibodies immunopreciptate 20% of the input Hnrnpa1 mRNA,
and 3% of control Sf3b1 mRNA, which encodes a core
spliceosomal component. The formaldehyde crosslinking experi-
ment controls for the possibility of QK repartioning during extract
preparation, while the uncrosslinked experiment confirms that the
crosslinking agent is not capturing a transient association.
To determine whether QK binds the QSBE within the Hnrnpa1
39 UTR with high affinity and specificity, we used gel mobility shift
and fluorescence polarization (FP) assays to measure the
association of recombinant, purified QK RNA-binding domain
with a 30 nucleotide synthetic RNA derived from the Hnrnpa1 39
Author Summary
Myelin is a lipid-rich structure that insulates neuronal
axons, facilitating electrical conductance and protecting
neurons from degeneration. Myelin comprises multiple
compact layers of phospholipid bilayer and specific myelin
proteins that occupy distinct positions within the struc-
ture. In the central nervous system, an RNA–binding
protein termed Quaking is required for formation of
compact myelin. Quaking regulates the production of
several myelin-related proteins by binding to their mRNAs.
Quaking controls the overall levels of these proteins and
controls the relative amount of sequence variants of the
proteins generated through alternative splicing. Here, we
identify a new Quaking mRNA target, the Hnrnpa1
transcript. We show that Quaking regulates the overall
level of hnRNP A1. Because hnRNP A1 is itself an RNA
regulatory factor and has been implicated in the control of
alternative splicing, regulation of hnRNP A1 by Quaking
may have consequences for the expression of multiple
additional targets. We show that hnRNP A1 and Quaking
regulate an overlapping set of transcripts and exons in
myelin-forming cells of the central nervous system.
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binding was 3662 nM; a U to G mutation within the QSBE
reduced binding by .50-fold (Figure 2D, 2E). The previously
identified Mbp QSBE bound with an apparent Kd of 4462 nM,
and the interaction was competed with a 12-nucleotide Hnrnpa1
RNA containing the core ACUAAY motif (Figure 2E).
QK controls Hnrnpa1 mRNA abundance and translational
efficiency
We used the GFP reporter assay to test whether the QSBE from
Hnrnpa1 functions in cultured CG-4 cells (Figure 3A). The U to G
point mutation within the Hnrnpa1 39 UTR that eliminated QK
binding in vitro (Figure 2D) reduced reporter mRNA level by
approximately five-fold (relative expression 0.2160.04, p=0.001),
consistent with a role for QK in promoting mRNA stability
(Figure 3B). As with the Mbp reporter, the binding site mutation
had a small increase on the amount of fluorescent protein
produced (1.3660.2, p=0.001) (Figure 3C). The same increase
was also observed using an independent dual luciferase reporter
assay in which the Hnrnpa1 39 UTR containing the wild-type or
the U-to-G point mutant QSBE was inserted into the Renilla
reniformis luciferase 39 UTR (1.960.5, p=0.02) (Figure 3D). Renilla
expression also increased in a CG-4 cell line that stably expresses a
Qk shRNA
miR (1.5360.05, p=0.04)(Figure 3D). We were unable
to test the effect of Qk shRNA
miR in the GFP reporter assay
because the shRNA
miR construct also expresses GFP.
To obtain a measure of translational efficiency, we divided the
normalized reporter fluorescence by the normalized amount of
reporter mRNA [35]. Translational efficiency of the QSBE mutant
Hnrnpa1 39 UTR was increased (6.5861.66, p=0.014) compared to
the construct without the mutation (Figure 3E), indicating that the
QSBE mutation increases the efficiency of translation of the reporter
transcript. We were not able to determine reporter mRNA
concentration using the luciferase reporter assay because of persistent
contaminating reporter DNA. Together the data establish that QK
binds the Hnrnpa1 39 UTR through the QSBE and that this binding
enhances Hnrnpa1 mRNA stability but reduces its translation. The
results parallel the data collected using the Mbp reporter.
Figure 1. The QSBE is a regulatory element in the Mbp 39 UTR. (A) Schematic drawing of the fluorescence reporter assay. (B) Constructs used
in reporter assays. The Mbp 39 UTR or the Mbp 39 UTR with the U to G point mutation were inserted into the 39 UTR of phrGFPII-1. tdTomato was
unmodified and served as a transfection control. (C) tdTomato and GFP mRNA level were measured by real time RT-PCR from cells co-transfected with
the indicated GFP construct and the tdTomato transfection control. The data in the graph are the average and standard deviation of six replicates
from two independent experiments. The ratio of green to red fluorescence intensity was determined from nine replicates in three independent
experiments. The graph represents the average and standard deviation. The normalized reporter fluorescence was divided by the normalized reporter
mRNA to obtain a measure of translational efficiency. Error bars represent the error propagated from the standard deviation of the reporter
fluorescence and real time RT-PCR data.
doi:10.1371/journal.pgen.1001269.g001
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Hnrnpa1. However, Hnrnpa1 expression is also regulated in 39-
UTR-independent ways. For example, hnRNP A1 is known to
regulate its own alternative splicing [36]. Moreover, hnRNP A1
protein stability or indirect regulation of hnRNP A1 transcription
would not factor into reporter expression measurements. It is
therefore important to determine the overall effect of QK on the
amount of endogenous hnRNP A1. We measured Hnrnpa1 mRNA
and protein levels in the Qk shRNA
miR knockdown CG-4 cell line
compared to a non-targeting shRNA
miR line (Figure 4A) by qRT-
PCR and Western blot. The Qk knockdown line exhibited a four-
fold decrease in endogenous Hnrnpa1 mRNA (0.2560.18,
p=0.012), which matches the effect of mutating the QSBE in
the Hnrnpa1 39-UTR reporter. We also observe a four-fold
reduction in hnRNP A1 protein (0.2460.25, P=0.018) in the
Qk shRNA
miR line (Figure 4B, 4C), which contrasts with our 39-
UTR reporter data. Thus, we conclude that QK has a net positive
effect on hnRNP A1 expression in CG-4 cells, and that QK-
dependent regulation of Hnrnpa1 mRNA stability is more
important to endogenous hnRNP A1 expression than control of
translation efficiency, at least in CG-4 oligodendrocyte precursors.
hnRNP A1 regulates Mag exon 12 alternative splicing
Because hnRNP A1 represses alternative splicing, misregulation
of hnRNP A1 is predicted to alter splicing patterns in the Qk
qk
mouse brain. Wu et al. [14] identified splicing changes in the
Figure 2. QK binds to an element in the Hnrnpa1 39 UTR. (A) Mouse, rat, and human Hnrnpa1 39 UTRs contain the ACUAA element in a
conserved UTR region. Also included are the sequences analyzed by gel shift and fluorescence polarization assays, including the U to G point mutant,
and the Mbp QSBE for comparison. (B) Hnrnpa1 mRNA co-immunoprecipitated with QK from mouse brain lysate. Lanes are as indicated. (C) Hnrnpa1
mRNA co-precipitated from a lysate prepared from formaldehyde crosslinked mouse brain tissue. Lanes are as indicated. Products were detected in
an ethidium bromide stained gel. (D) Electrophoretic mobility shift assays demonstrate a high affinity interaction between QK and the wild type
Hnrnpa1 QSBE in vitro. The U to G point mutant, QSBE Mut, did not interact. (E) EMSA and fluorescence anisotropy assays demonstrating an
interaction between QK and the Mbp QSBE of similar affinity and competition of the interaction with a 12 nucleotide Hnrnpa1 39 UTR fragment
containing ACUAA. Error bars indicate the standard deviation of five reads of each polarization measurement for each experiment. The error indicated
for Kd, app and Kc, app is the standard deviation of at least three experiments.
doi:10.1371/journal.pgen.1001269.g002
QK Regulates hnRNP A1 Expression
PLoS Genetics | www.plosgenetics.org 4 January 2011 | Volume 7 | Issue 1 | e1001269brains of Qk
qk mice for three myelin-related transcripts: Mbp, Plp1,
and Mag. We therefore selected these mRNAs for further analysis.
For Mag, we analyzed the ratio of S-Mag, which includes the
alternatively spliced exon 12, to L-Mag, in which the exon is
skipped. Inclusion of this exon is increased in Qk
qk mice despite the
overall reduction of QK in each [14,16]. Control CG-4 cells
transfected with the GFP plasmid and selected in G418 contained
an S-Mag to L-Mag isoform ratio of 2.460.2 (Figure 5A).
Reduction of QK with Qk siRNA caused an increase in the
amount of S-Mag compared to L-Mag, resulting in an isoform ratio
of 4.761.2 (p=0.04, Figure 5A, 5C). The increase is similar to
that previously observed by others in the Qk
qk mouse brain,
confirming that QK controls Mag splicing in CG-4 cells as it does
in brains. CG-4 cells transfected with Hnrnpa1 siRNA displayed an
increased isoform ratio of 5.061.7 (p=0.01) (Figure 5A, 5C). The
direction of the change is consistent with a role for hnRNP A1 in
splicing repression and with our observation that QK has a net
positive effect on hnRNP A1 expression in CG-4 cells.
Transfection with control, Hnrnpc,o rSfrs5 siRNAs did not
significantly alter the isoform ratio (Figure 5A, Figure S4). The
data indicate that hnRNP A1 regulates Mag exon 12 splicing and
suggest that QK control of Mag splicing may be indirect.
We also examined alternative splicing of Plp1 and Mbp. RT-
PCR analysis of Mbp alternative splicing did not reliably confirm
the QK-dependence in CG-4 cells (data not shown). To further
examine Plp1 splicing in QK knockdown and in hnRNP A1
knockdown CG-4 cells, RT-PCR primers were designed to
determine the relative ratio of Plp1, which contains a longer exon
3 variant due to alternative 59 splice site selection, to Dm20,a
transcript containing the shorter exon 3 variant. While QK siRNA
reduced the amount of Plp1 compared to Dm20, mirroring the
change observed in Qk
qk mouse brains, there was no detectable
change upon transfection with Hnrnpa1 siRNA (Figure 5B, 5C).
The data suggest that for Plp1, QK controls alternative splicing not
through hnRNP A1 but, instead, through some other mechanism.
Microarray assay design
Because QK positively regulates hnRNP A1 in CG-4 cells, we
anticipated that the isoform ratio of many transcripts in addition to
Mag and Plp1 would be altered upon QK knockdown. To test this
hypothesis, we used Affymetrix 1.0 ST exon microarrays to assess
global changes in gene expression in response to QK depletion
(Figure 6A). To reduce the likelihood of detecting off-target effects
or changes in gene expression brought about by the clonal
selection procedure, we also analyzed cells that were prepared by
transient transfection with Qk siRNA (Ambion) along with a GFP-
expressing plasmid that allows selection with a different drug than
that used for stable cell line production. After two days of selection,
the Qk siRNA reduces Qk expression by approximately 80%, while
the control siRNA does not (Figure 6B). In parallel, we also
analyzed changes caused by depleting hnRNP A1 by transient
transfection of a corresponding siRNA. Depletion of hnRNP A1
was confirmed by Western blotting (Figure 6C). Three indepen-
dent biological replicates were analyzed for each group. In
addition to the Qk shRNA, Qk siRNA, and Hnrnpa1 siRNA groups,
we also assayed gene expression in control cells treated with non-
silencing shRNA, non-silencing siRNA, and untreated CG-4 cells.
Identification of transcripts controlled by QK in
oligodendrocyte precursors
We first wished to identify the set of transcripts regulated by QK
at the level of transcript abundance. At a False Discovery Rate
(FDR) of 0.1 (step-up, p-value 0.0012), 224 transcripts were
identified with a p-value at or below the cut-off (Figure 7A, Table
Figure 3. QK controls reporter expression through the QSBE in
the Hnrnpa1 39 UTR. (A) Constructs used in reporter assays. The
Hnrnpa1 39 UTR or the Hnrnpa1 39 UTR with the U to G point mutation
was inserted into the 39 UTR of phrGFPII-1. tdTomato was unmodified
and served as a transfection control. For the luciferase assays, the firefly
luciferase transfection control was encoded on the same plasmid as the
experimental Renilla luciferase. The wild type or mutant Hnrnpa1 39 UTR
was cloned behind Renilla. (B) Two color fluorescence reporter assays
conducted with the Hnrnpa1 39 UTR and the U-to-G QSBE point
mutation. (B) RNA level and (C) reporter fluorescence were assayed as in
Figure 1. The RNA data represent the average and standard deviation of
nine replicates from three independent experiments. The fluorescence
data represent the average and standard deviation of 27 replicates from
9 independent experiments. (D) Dual luciferase reporter experiments,
where the wild type or U-to-G point mutant Hnrnpa1 39 UTR was
inserted into the 39 UTR of Renilla reniformis luciferase, and Firefly
luciferase expressed from the same vector served as a transfection
efficiency control. The dual reporter was transfected into CG-4 cells or a
CG-4 cell line that stably expresses a Qk shRNA
miR. The relative activities
of firefly and Renilla luciferase were determined using a plate reader.
Error bars indicate the standard deviation of five independent replicates
for the CG-4 cells or variance of two replicates for the shRNA
miR cell line.
(E) GFP reporter translational efficiency was determined by dividing the
relative amount of reporter protein by the relative amount of reporter
mRNA. The error was propagated from the standard deviations in (B)
and (C) as in Figure 1 and as described in methods.
doi:10.1371/journal.pgen.1001269.g003
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and 202 true positives. For this set of transcripts, the mean
expression of the three replicates was calculated and the log2 fold
change compared to untreated CG-4 cells was determined.
Hierarchical clustering (Pearson’s dissimilarity, centroid meth-
od) revealed that gene expression in the Qk siRNA and Qk shRNA
samples was highly correlated (Pearson’s correlation coefficient
0.88; Figure 7A), confirming our statistical selection of transcripts.
Gene expression changes in the control samples were less
correlated, indicating that we have identified changes in gene
expression due to the reduction of QK and not to other elements
of the experimental protocol. To confirm the array results, we used
quantitative RT-PCR to assess gene expression changes in the Qk
shRNA
miR stable cell line. Of fourteen transcripts tested, thirteen
had a difference in expression by quantitative RT-PCR
(Figure 7B). The transcript that had the greatest change in QK
knockdown cells was the previously identified QK target Mbp
(Figure 7B).
Gene ontology analysis revealed that myelin components were
significantly enriched, as predicted from the role of QK in
myelination (Table 1). Furthermore, the top ten decreasing
transcripts include two myelin components, Mbp and Plp1
(Figure 7B). Other enriched categories include epidermal growth
factor and acetylcholine receptor activities and tau protein
function, suggesting a widespread disruption of processes that
promote myelination. Epidermal growth factor receptor activity
has been shown to promote myelination in the mouse, while
acetylcholine receptor activity promotes oligodendrocyte survival
[37,38]. The tau pathway has been linked to oligodendrocyte
process formation [39].
A subset of QK targets are co-regulated by hnRNP A1
We next wished to compare the effects of reducing hnRNP A1
with the effects of reducing QK genome-wide. We identified
probesets with a significant change in expression upon QK
knockdown using an FDR set at 0.1 (step up, p-value 0.00012).
Hierarchical clustering (Pearson’s dissimilarity, centroid method)
demonstrated that the probeset expression changes in Hnrnpa1
siRNA treated cells clustered closely to those in Qk siRNA treated
cells (correlation coefficient 0.81) (Figure 7C). Qk shRNA and Qk
siRNA also clustered closely, as one would predict (correlation
coefficient 0.91) (Figure 7C). The correlation between expression
changes in the Hnrnpa1 siRNA and Qk knockdown groups was
independent of the False Discovery Rate (Figure S5). The data
indicate that there is similarity in the probeset level changes in
gene expression between the Qk knockdown and Hnrnpa1
knockdown samples genome-wide.
We repeated our analysis at the whole transcript level, selecting
transcripts regulated by QK (FDR 0.1) and performing the same
analysis as for probesets. Again, there is a strong correlation at the
whole transcript level between expression changes in the Hnrnpa1
siRNA and the Qk siRNA samples (Pearson’s correlation
coefficient 0.83) (Figure S6). This correlation is of a similar
magnitude to the correlation we observe between Qk shRNA and
Qk siRNA (Pearson’s correlation coefficient 0.88). These data
suggest that QK and hnRNP A1 exert similar pressures on gene
expression and alternative splicing on a genome-wide scale in
oligodendrocyte precursors.
hnRNP A1 motifs are enriched in QK-responsive exons
hnRNP A1 is a sequence-specific RNA binding protein that
regulates the isoform ratio of transcripts that contain a binding site
in or near exons that are alternatively spliced [40–42]. It binds to
several sequence variants, including the SELEX-derived
UAGGG(A/U) as well as UAGGU and related sequences
[43,44]. Our observation that QK regulates Hnrnpa1 expression
predicts that hnRNP A1 binding sites will be present in the vicinity
of QK-responsive exons.
In order to obtain a set of exons predicted to be alternatively
spliced upon Hnrnpa1 or Qk knockdown, we re-analyzed our
microarray data using AltAnalyzer [45] and the full Affymetrix
probeset annotation. The analysis identified both upregulated and
downregulated exons in both data sets. For Qk knockdown CG-4
cells, 78 exons were downregulated and 219 were upregulated,
and for Hnrnpa1 knockdown cells, 93 exons were downregulated
70 were upregulated.
To identify enriched motifs, we determined the frequency of all
5mers contained in the sequences of regulated exons relative to
Figure 4. QK regulates expression of endogenous Hnrnpa1. (A) QK protein was reduced in a CG-4 cell line stably transfected with a construct
expressing a Qk shRNA
miR compared to a control line expressing a nonsilencing shRNA
miR. (B) hnRNP A1 protein was detected by Western blotting
and Hnrnpa1 mRNA was detected by real time RT-PCR. Both protein and mRNA were reduced in the QK knockdown line compared to the control line.
Tubulin served as a loading control for both assays. (C) Representative Western blot images for the data presented in (A) and (B). Error bars indicate
the standard deviation of at least three replicates.
doi:10.1371/journal.pgen.1001269.g004
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statistical significance, we also determined the 5mer frequency
from ten sets of an equivalent number of randomly selected exons.
Significantly changed 5mers were identified based upon criteria of
a greater than 1.5 fold enrichment and a p-value of less than 0.05
when compared to the randomly selected exon set (Table S2). We
found a significant enrichment over random of 42 5mers in QK
upregulated exons, including the hnRNP A1 motif TAGGT (fold
enrichment FE=1.54, p=5610
23) and the QSBE motif ACUAA
(FE=1.54, p=8610
27, Figure 8A). The A1 motif is similar to an
exonic splicing silencer motif identified by Burge and co-workers
[46]. There are 149 significant enriched 5mers in QK downreg-
ulated exons. These include the hnRNP A1 motif TAGGT
(FE=1.94, p=3610
23), but not the QSBE ACUAA motif. While
Figure 5. hnRNP A1 co-regulates Mag alternative splicing. (A) RNA was prepared from cells that had been transiently transfected with
Hnrnpa1 or QK siRNA and selected with G418. RNA produced from CG-4 cells transfected with a control selection plasmid was analyzed alongside as a
control. Isoforms of Mag containing or lacking exon 12 were amplified by RT-PCR using fluorescent primers. Products were separated in 5%
acrylamide gels. Gels were scanned and the relative isoform ratio was calculated from the intensity profile of the lane using ImageGauge.
Representative intensity profiles are presented below representative gel images. Data and standard deviations were calculated from 3 (control siRNA
and Qk siRNA) or 5 (GFP control and Hnrnpa1 siRNA) independent transfections. An increase in expression of the longer isoform was detected upon
transfection of both Hnrnpa1 and Qk siRNA. (B) Plp1 and Dm20 isoform ratios were analyzed as described above for Mag. A decease in expression of
the upper isoform was detected when Qk siRNA was transfected but not when Hnrnpa1 siRNA was transfected. (C) Qk and Hnrnpa1 knockdown were
confirmed by qRT-PCR.
doi:10.1371/journal.pgen.1001269.g005
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randomly selected exons also yields a significantly changed p-
value. As expected, hnRNP A1 motifs were also enriched in the
hnRNP A1 knockdown cells (Figure 8A: upregulated exons;
TAGGT, FE=2.32, p=4610
26; downregulated exons: TAGGT,
FE=2.2, p=4610
24; TAGGG, FE=2.5, p=1.7610
25). The
enrichment of the hnRNP A1 motif in QK-responsive exons
suggests that many but not all QK-dependent alternative splicing
events are mediated indirectly by hnRNP A1. The enrichment of
the QK motif is consistent with a direct role for QK in the
regulation of some alternative splicing events.
Discussion
The RNA binding protein QK controls myelination by
governing the stability, subcellular localization, and alternative
Figure 6. Microarray assay design. (A) Diagram of knockdown cell populations and controls. QK was reduced with Qk shRNA
miR and Qk siRNA.
hnRNP A1 was knocked down with siRNA. Control samples consisted of untransfected CG-4 cells, CG-4 cells transfected with nonsilencing siRNA,
stably transfected CG-4 cells expressing a nonsilencing shRNA
miR, and differentiated CG-4 cells. Each group was assayed in triplicate using three
biological replicates. (B) Real time RT-PCR demonstrating QK reduction in the Qk shRNA
miR stable cell line and in CG-4 cells transiently transfected
with Qk siRNA. Data are the mean of three replicates +/2 standard deviation. Error was propagated from the Qk and Tubulin standard deviations. (C)
Western blot demonstrating hnRNP A1 knockdown in CG-4 cells.
doi:10.1371/journal.pgen.1001269.g006
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PLoS Genetics | www.plosgenetics.org 8 January 2011 | Volume 7 | Issue 1 | e1001269Figure 7. Identification of the QK and hnRNP A1 regulatory networks in CG-4 cells. (A) Hierarchical clustering demonstrated high
correlation in the gene expression changes between the two knockdown populations. Transcripts altered by QK depletion were identified using a
two sample t-test and an FDR of 0.1 (p-value cutoff 0.0012). For the selected transcripts, the expression values of the three biological replicates were
averaged and the fold change compared to untransfected CG-4 cells was calculated. The resulting values were clustered (Pearson’s dissimilarity,
centroid method), and correlation coefficients were calculated. (B) Real time PCR confirmation of microarray results. RNA was extracted from the Qk
shRNA
miR knockdown cell line and from the nonsilencing shRNA
miR control cell line. Real time PCR was performed in triplicate. Expression values were
normalized to tubulin as a loading control. Data are the mean of three replicates, expressed at log2 for comparison to the microarray results. (C) QK-
dependent probeset expression changes are highly correlated with probeset expression changes caused by hnRNP A1 depletion. Individual
probesets with expression changes in response to QK knockdown were identified using a two-sample t-test, comparing the knockdown groups to
the control groups. The mean of each group was determined and the difference from the CG-4 cell line was calculated. Values were clustered as in
(A). Correlation coefficients were calculated using Partek GS software. Probesets were selected for clustering based solely on their change in the QK
knockdown samples.
doi:10.1371/journal.pgen.1001269.g007
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direct QK targets have been characterized, and the mechanism by
which QK regulates such diverse processes is unclear. Here, we
show that the QSBE sequence—the primary determinant for high
affinity QK binding—is required for regulation of Mbp mRNA.
Moreover, we show that QK directly regulates the transcript
encoding the splicing factor Hnrnpa1 through a conserved QSBE
in its 39 UTR. The strong correlation between the changes in
transcript and probeset abundance upon Qk or Hnrnpa1 knock-
down is consistent with a vertical regulatory relationship and
suggests that hnRNP A1 is a primary effector of QK function.
The reporter data reveal that QK has two opposing effects on
Mbp and Hnrnpa1 expression, positively regulating mRNA
abundance while negatively regulating translational efficiency.
The mode of regulation is consistent with a model where QK
stores its targets in a translationally quiescent but stable complex.
Such a regulatory scheme would enable a transient burst of
translation in response to a signal that releases QK from its targets,
such as phosphorylation. Consistent with this hypothesis, Feng and
co-workers have shown that QK activity is regulated by tyrosine
phosphorylation and that the level of phosphorylation is
modulated during myelination [47].
The microarray analysis described herein delineates the set of
transcripts controlled by QK in the CG-4 oligodendrocyte
precursor cell line. The most dramatically changed transcript is
the previously characterized QK target Mbp [10,13]. We have also
observed striking changes in the expression of several other
important myelin genes, suggesting that QK has broad control of
transcripts important for myelination. For example, Cnp1 has been
implicated in maintaining the integrity of myelinated axons [1].
Fyn stimulates Mbp transcription, suggesting control of Mbp
expression by QK is both direct and indirect [48]. Finally, UDP
glycosyltransferase 8 (Ugt8) produces myelin sphingolipids,
suggesting that QK controls synthesis of the lipid components of
myelin as well.
Several labs have demonstrated that hnRNP A1 is a post-
transcriptional regulator of gene expression. hnRNP A1 represses
alternative splicing when associated with silencing elements near
spice sites [40–42]. Additional functions have also been proposed.
hnRNP A1 also binds to telomeric DNA, where it is thought to
promote telomere elongation [49]. Furthermore, hnRNP A1 is
implicated in the Drosha-mediated processing of a primary
microRNA [50,51]. It will be interesting to determine whether
the effects of QK on gene expression in oligodendrocyte
precursors are mediated by hnRNP A1 through any of these
mechanisms.
The data also have implications for the mechanism by which
hnRNP A1 regulates Mag alternative splicing. An hnRNP A1
motif is present in Mag intron 12 immediately downstream of the
59-splice site (Figure 8B), suggesting a model in which binding of
hnRNP A1 to this motif blocks 59-splice site recognition,
promoting skipping of exon 12. Consistent with this model, our
data and the work of others show that reduction of QK or hnRNP
A1 increases MAG exon 12 inclusion [14]. Moreover, a point
mutation in this hnRNP A1 binding motif has been shown to
cause constitutive exon 12 inclusion [14], although we note that
this mutation also strengthens the 59-splice site consensus, which
confounds a simple interpretation of this result.
The microarray analysis suggests that some of the effects of QK
on splicing may be indirect. In line with these observations,
screening the 39 UTRs of the QK responsive transcripts using the
sequence analysis tool Patscan [52] reveals that under a third
contain the sequence element required for QK binding (Table S3).
Together, these observations suggest numerous indirect changes in
gene expression caused by QK depletion. Consistent with this
hypothesis, we observe enrichment of 5mer motifs that do not
correspond to QK or hnRNP A1 binding motifs in QK-responsive
exons (Table S2). These may represent binding sites for other
RNA regulators.
Understanding how QK controls its network of transcripts will
require a detailed analysis of directly bound QK targets in
oligodendrocyte lineage cells. Use of the cross-linked immunopre-
cipitation technique [53–56] should greatly facilitate such an
analysis. A recent study used a variant of the technique, in which
chemically modified nucleotides were incorporated into mRNAs
in HEK293 cells overexpressing QK to enhance crosslinking [27].
Despite the fact that the mRNAs expressed in HEK293 are likely
to be substantially different from those expressed in oligodendro-
cyte lineage cells, 20% of the transcripts identified in our
microarray analysis are present the list of crosslinked transcripts,
more than the 11–13% overlap when the list of transcripts
crosslinked to Pumilio 2 or TNRC6 are analyzed as controls.
Numerous studies have implicated QKI and other myelin genes
in SCZ. Thirty-eight genes that have been implicated in SCZ [57]
are affected by Qk knockdown, including CNP, MBP, PLP1, and
OMG (Table S4). Additionally, SCZ brains have similar splicing
defects to those observed in association with Qk knockdown,
including changes in MAG, NCAM, and ERBB4 [16,21,58]. Thus,
Table 1. Top 10 enriched gene ontology terms in QK knockdown samples.
Function Enrichment Score % genes in pathway that are present GO ID
acetylcholine receptor regulator activity 21.9556 100 30548
response to organic nitrogen 19.1296 33.3333 10243
positive regulation of synaptic transmission 13.2249 33.3333 50806
regulation of transmission of nerve impulse 12.7344 12.6214 51969
myelin sheath 12.5974 42.8571 43209
epidermal growth factor receptor binding 12.5974 42.8571 5154
receptor regulator activity 12.5974 42.8571 30545
positive regulation of transmission of nerve impulse 12.3089 30.7692 51971
tau protein binding 11.989 66.6667 48156
tau-protein kinase activity 11.989 66.6667 50321
*Transcripts selected at FDR 0.2.
doi:10.1371/journal.pgen.1001269.t001
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may provide a link between QKI function and disease.
Gene dosage effects have been implicated in many other human
diseases. For example, Pelizaeus-Merzbacher disease is associated
with PLP1 duplication [59]. Intriguingly, copy number variation
has been linked to schizophrenia, Charcot-Marie-Tooth disease,
and autism, suggesting that small variations in the dosage of
important myelin related genes can have significant clinical
outcome [60–62].
In summary, we have identified a new direct QK target, the
Hnrnpa1 transcript, in oligodendrocyte lineage cells. Additionally,
we have identified the set of transcripts directly or indirectly
controlled by QK and have shown that hnRNP A1 co-regulates
part of this set. The results suggest that the importance of QK for
myelin formation lies not only in the identity of major direct
targets, but also in the network of secondary targets under QK
control. They also demonstrate that QK is a prime regulatory
factor controlling gene expression in oligodendrocyte precursors
Figure 8. hnRNP A1 motifs are enriched in QK-responsive exons. (A) Relative 5mer frequencies in exons that change in response to QK or
hnRNP A1 knockdown were binned according to fold enrichment compared to frequency in all exons. The position of hnRNP A1 and QK motifs is
annotated by an arrow. The significance of the enrichment was determined by comparison to 5mer fold enrichment in ten groups of an equivalent
number of exons selected at random. (B) An hnRNP A1 motif (gray box) is present in Mag intron 12 immediately downstream of the 59-splice site
(arrow). The position of the mutation that causes constitutive Mag exon 12 inclusion is boxed [14].
doi:10.1371/journal.pgen.1001269.g008
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Brain tissue was harvested from mice in accordance with
protocols approved by the University of Massachusetts Medical
School Institutional Animal Care and Use Committee. The
animal care program complies with Federal and State laws and the
PHS policy on Humane Care and Use of Laboratory Animals.
The experiments were designed in order to minimize the number
of animals used.
Cell culture and transfections
The CG-4 rat oligodendrocyte precursor and B104 cell lines
were a gift from Lynne Hudson and were cultured according to
Louis et al. [29]. CG-4 cells were maintained as undifferentiated
progenitors in the presence of 30% B104 conditioned medium for
the duration of the assays except as noted otherwise. Cells were
transfected with Lipofectamine 2000 (Invitrogen) according to
instructions from the manufacturer. Where indicated, 24 hours
after transfection, transfected CG-4 cells were selected by
incubation with 1500 ng/ml G418 (Geneticin, Invitrogen) for 48
to 72 hours.
To generate stable cell lines, cells were transfected as above with
the indicated shRNA
miR constructs (Open Biosystems). After
24 hours, cells were trypsinized and plated sparsely on 150 mm
plates in the presence of 2 ng/ml puromycin. Cells were allowed to
proliferate for approximately two weeks, until colonies had
formed. Colonies were picked and transferred into 24 well plates
to proliferate.
Plasmids and siRNAs
The Hnrnpa1 39 UTR (RefSeq NM_0104447) was cloned into
the phrGFPII-I plasmid (Strategene) after PCR amplification
from an Hnrnpa1 full length I.M.A.G.E. clone (Invitrogen). The T
to G mutation in the QSBE was introduced by QuikChange site
directed mutagenesis (Stratagene). Sequences of all constructs
were confirmed by sequencing. tdTomato was provided by Roger
Tsien and colleagues [63]. To generate a construct for expressing
tdTomato in mammalian cells, the tdTomato coding sequence
was excised from the original plasmid and cloned into the
pcDNA 3.1+ expression vector (Invitrogen). The vector psiCheck
2 was a gift from Phil Zamore. The Hnrnpa1 wild type and
mutant UTRs were cloned from the GFP expression vectors into
psiCheck2.
Qk siRNA1, Hnrnpa1 siRNA, and the non-targeting control
siRNA were commercially designed (Ambion). The Qk pGIPZ
shRNA
miR (Open Biosystems) was obtained from the University of
Massachusetts RNAi core facility.
Reporter assays
For the fluorescent reporters, CG-4 cells were seeded onto the
surface of a 24 well plate and, after 24 hours, transfected with
0.6 mg of the plasmid encoding GFP with or without a UTR of
interest and 0.1 mg of the tdTomato control plasmid using
Lipofectamine 2000 (Invitrogen). Complexes were formed in
medium without antibiotic or other supplements. Transfections
were done in DMEM containing N1 supplements, biotin, insulin,
L-glutamine, but without antibiotic or B104 conditioned medium.
After 24–48 hours of incubation at 37uC, the plate was read using
a Victor3 plate reader (Perkin Elmer). GFP was excited using a
485 nm filter and detected through a 519/20 filter. tdTomato was
excited using a 531/25 nm filter and detected through a 580/10
filter. All filters were purchased from Chroma. Each well was read
25 times, in a 5 by 5 grid with 0.1 mm spacing between the spots.
The well average was computed from these 25 spots. GFP
fluorescence was divided by tdTomato fluorescence to control for
transfection efficiency and cell density. Three or four indepen-
dently transfected wells were averaged for each experiment and
the standard deviation was calculated.
For the luciferase reporters, cells were transfected as above with
the plasmid psiCheck2 (Promega) or a cloned psiCheck2 variant
with the hnRNP A1 wild type or T to G mutant 39 UTR cloned
behind Renilla. 24–48 hours after transfection, cells were lysed in
150 ml of lysis buffer per well and dual luciferase assays were
conducted using the Dual Luciferase Assay System (Promega)
according to the manufacturer’s instructions.
RNA binding assays
For the gel shift assays, recombinant QK was purified as
previously described [25]. RNA gel shifts and fluorescence
polarization assays were performed according to [64], with the
exception that electrophoresis was carried out in a non-denaturing
5% polyacrylamide slab gel in 1xTBE buffer. RNA co-IPs from
uncrosslinked lysates were conducted according to Tenenbaum
et al. [65], using brains from C57BL/6 mice. Formaldehyde
crosslinking of mouse brain tissue and immunoprecipitation from
crosslinked lysate was conducted as described in [66]. After cross-
link reversal, RNA was extracted with Trizol reagent according to
the manufacturer’s instructions, the purified RNA was treated with
DNase (Ambion Turbo DNAfree), and co-precipitated RNA was
amplified by one step RT-PCR (Invitrogen) with transcript specific
primers. Antibodies to QK (Bethyl labs) and 6xHisG (Invitrogen)
were commercially obtained. PCR primers were fluorescently
labeled at the 59 end unless otherwise noted. After separating the
PCR product from free primers by agarose gel electrophoresis, gels
were imaged on a Fuji FLA-5000 using a blue laser.
Quantitative PCR
RNA was extracted from cultured cells with Trizol Reagent
(Invitrogen) and treated with Turbo DNAfree (Ambion) or RQ1
DNase (Promega) according to the provided instructions. The
yield was determined by spectrophotometry. Real time RT-PCR
was performed using a one-step RT-PCR kit (Qiagen or Bio-Rad)
according to the manufacturer’s instructions and cycled on an
Opticon thermal cycler (Bio-Rad). All assays were performed in
triplicate. For each target the presence of a single product after
cycling was confirmed by agarose gel electrophoresis. Data were
analyzed by comparison to a 5-point standard curve constructed at
the time of cycling or according to the method of Rutledge [67].
GAPDH or tubulin and tdTomato were used for normalization as
indicated in the figure legends.
Splicing assays
CG-4 cells were transfected as for the dual color fluorescence
reporter assay, using 20 nM siRNA and 0.3 mg GFP-selection
plasmid per well. After 24 hours, the medium was replaced with
30% B104 conditioned medium containing 1500 ng/ml Geneticin
(Invitrogen). Cells were incubated in the selection medium for
48 hours, then washed two times with PBS. RNA was isolated with
Trizol (Invitrogen). PCR was conducted with 59 fluorescein
labeled primers and the products were isolated on a non-
denaturing 5% polyacrylamide gel. Gels were imaged on a Fuji
FLA-5000 imager using a blue laser. Band intensity in each lane
was quantified using ImageGauge profile analysis.
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CG-4 cells were grown and transfected as described above.
RNA was extracted in Trizol (Invitrogen). RNA was further
purified and genomic DNA was eliminated using the RNEasy Plus
mini kit (Qiagen). Knockdown of Qk or Hnrnpa1 was verified by
quantitative RT-PCR. Rat Exon 1.0 ST microarrays were
obtained from Affymetrix. Three independent biological replicates
were assayed per group. Sample labeling and array hybridization
were conducted by the University of Massachusetts Genomics
Core Facility according to Affymetrix procedures. Data were
analyzed with Partek GS, using the Affymetrix extended probeset
annotation with a GC background correction RMA algorithm.
Differentially expressed mRNAs and probesets were identified
using a two-sample t-test, with an FDR of 0.1 unless otherwise
noted. For analysis of the Hnrnpa1 knockdown groups, probesets
and transcripts that significantly changed in response to QK
depletion were selected, then the changes in expression in response
to hnRNP A1 depletion were clustered alongside the other control
and experimental groups.
Statistical analyses
All assays were performed in triplicate unless otherwise
indicated. Error bars represent the standard deviation of the
experimental replicates. P-values were calculated from a two-
sample t-test assuming unequal variance. Errors were propagated
from the individual standard deviations according to the formula
DZ=Z(SQRT(((DA/A)‘2)+((DB/B)‘2))) where Z=A/B.
5mer enrichment analysis
The sequences of regulated exons were obtained from
Affymetrix. Exons from all rat genes were obtained from the
UCSC genome browser. The frequency of 5mers in each exon was
determined using Perl scripts. Random sets of exons were selected
using Perl scripts. The average and standard deviation of 5mer
frequency were calculated for the random sets of exons to obtain a
p-value for fold enrichment significance.
Supporting Information
Figure S1 Two color fluorescence reporter assay. (A) CG-4 cells
transfected with GFP, tdTomato, or co-transfected with both
could be distinguished based upon red and green fluorescence. (B)
CG-4 cells co-transfected with GFP and tdTomato plasmids
exhibited both red and green fluorescence. (C) Red and green
fluorescence could be distinguished with virtually no bleed through
between the fluorescence channels.
Found at: doi:10.1371/journal.pgen.1001269.s001 (0.80 MB TIF)
Figure S2 QK does not interact with the Mag QASE or the Plp1
ESE. (A) The Mag intron 12 QASE and the Plp1 exon 3 ESE do
not contain the high affinity QK binding element ACUAA or the
related sequence AUUAA. (B) The Mag QASE and the Plp1 ESE
do not bind QK with high affinity in vitro. Three overlapping
fragments of the QASE or the ESE sequence, diagramed in (A),
were equilibrated with recombinant QK in vitro and analyzed by
electromobility shift assays. The positive control Mbp QSBE
fragment does interact with QK.
Found at: doi:10.1371/journal.pgen.1001269.s002 (0.82 MB TIF)
Figure S3 QK co-precipitates with Hnrnpa1 mRNA but not
other splicing factors. Formaldehyde crosslinked mouse brain
lysate was immunoprecipitated with QK or control His6G
antibodies. Co-precipitated RNA was purified and specific RNAs
were amplified by RT-PCR followed by separation on an agarose
gel. Lanes are as indicated. Note that the Sfrs5 and Hnrnpa1 gel
images are the same as those presented in Figure 2.
Found at: doi:10.1371/journal.pgen.1001269.s003 (0.24 MB TIF)
Figure S4 QK but not SFRS5 or hnRNP C regulates Mag exon
12 inclusion. The isoform ration of Mag was assessed as in Figure 5.
Transfection with two different Sfrs5-targeted siRNAs or two
different Hnrnpc-targeted siRNAs does not appreciably alter Mag
isoform ratio relative to control siRNA or a GFP transfection
control. In contrast, transfection of a Qk targeting siRNA increases
Mag exon 12 inclusion by two-fold.
Found at: doi:10.1371/journal.pgen.1001269.s004 (0.90 MB TIF)
Figure S5 Correlation coefficient as a function of false discovery
rate. Microarray probeset expression values were analyzed as
described in the text, for four different False Discovery Rates.
Briefly, probesets with changes in expression in both of the Qk
knockdown groups were selected at the desired FDR. Expression
values for the three biological replicates were averaged and the
difference from the control CG-4 value was calculated. Correla-
tions between the changes in expression for the indicated groups
were calculated using Partek GS Software.
Found at: doi:10.1371/journal.pgen.1001269.s005 (0.34 MB TIF)
Figure S6 Correlation between Hnrnpa1 knockdown and Qk
knockdown samples at the transcript level. QK-dependent
transcript expression changes are correlated with transcript
expression changes caused by hnRNP A1 depletion. Transcripts
with expression changes in response to Qk knockdown were
identified using a two sample t-test, comparing the knockdown
groups to the control groups. The mean of each group was
determined and the difference from the CG-4 cell line was
calculated. Values were clustered as described for Figure 7 for
probesets.
Found at: doi:10.1371/journal.pgen.1001269.s006 (0.62 MB TIF)
Table S1 Transcripts significantly changed in response to QK
knockdown in CG-4 oligodendrocyte precursor cells.
Found at: doi:10.1371/journal.pgen.1001269.s007 (0.05 MB
XLS)
Table S2 Enriched 5mers in alternatively spliced exons.
Found at: doi:10.1371/journal.pgen.1001269.s008 (0.11 MB
XLS)
Table S3 Transcripts found to decrease upon QK depletion and
containing a QSBE within their 39 UTR.
Found at: doi:10.1371/journal.pgen.1001269.s009 (0.04 MB
XLS)
Table S4 Genes implicated in SCZ that change upon QK
depletion.
Found at: doi:10.1371/journal.pgen.1001269.s010 (0.03 MB
XLS)
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